Brief: Generation Bio Provides Update on Preclinical Studies for Hemophilia A Program

Generation Bio

14/12/2021 12:33

Dec 14 (Reuters) - Generation Bio Co  GBIO.O :
    * GENERATION BIO PROVIDES UPDATE ON PRECLINICAL STUDIES FOR
HEMOPHILIA A PROGRAM
    * GENERATION BIO CO - NON-HUMAN PRIMATES (NHPS) DEMONSTRATED
UP TO
2% NORMAL HUMAN FACTOR VIII EXPRESSION
    * GENERATION BIO - INNOVATIONS IN CLOSED-ENDED DNA  AND
CTLNP
PRODUCTION PROCESSES GENERATED PEAK MEAN OF 205% NORMAL HUMAN
FACTOR VIII EXPRESSION IN MICE
    * GENERATION BIO - IN MOUSE STUDIES, RES-DERIVED CEDNA
DELIVERED
BY CTLNP GENERATED PEAK MEAN HUMAN FACTOR VIII EXPRESSION OF
205% OF NORMAL AT 2.0 MG/KG

Source text for Eikon:  ID:nGNXbGR42Y 
Further company coverage:  GBIO.O 

 ((Reuters.Briefs@thomsonreuters.com;;))